ÌÇÄò²¡×ã/»¤Àí,diabetic foot /nursingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õþ¸®¾ÈÖú,government succorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØÆ¤ÏÂ×¢Éä,Multipe subcutaneous insulin infectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Ê²Ý¼å¼Á,liquorice decoctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Äò¦Á1-΢Çòµ°°×,Urine ¦Á1-microglobulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ŵºÍ±Ê,Nohe PenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºóÄÒÏ»ì×Ç,posterior subcapsular opacitiesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶¯Ì¬ÑªÌÇ,dynamic glucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡´óѪ¹Ü²¢·¢Ö¢,Macrovascular DiseasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
2ÐÍ/²¡ÀíÉúÀíѧ,type 2/physiopathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔçÆÚ¸ÉÔ¤ÖÎÁÆ,Early intervening treatmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÖ¬´úлÒì³£,Disorder of Glucolipide MetabolismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍâÀ´»é¼ÞÅ®,non-native married femaleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚ·ÖÃÚϵͳ¼²²¡,endocrine system diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÇÖÊÊèËÉÖ¢/²¢·¢Ö¢,Osteoporosis/ complicationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á¬ÐøÐÔ½¡¿µ½ÌÓý,continuous health educationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÕÄ©ÆÚÌÇÄò²¡Éö²¡,End-stage diabetic nephropathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾«µ°°×ÒȵºËØ,Human NPH insulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÀÅÁ˾ËûƬ,Epalrestat tabletÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßÌǵÍÖ¬ÉÅʳ,high-carbohydrate/low-fat dietÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¡Òò·ÖÐÍ,Pathogeny typesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö«Ì幦Äָܻ´,restoration of limb functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³õÖÎ,de novoÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°×ϸ°û½éËØ16,interleukin-16Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖкÍÄÜÁ¦,neutralization abilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àëĸõòüºÏÎï,Polypeptide chromium chelateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢´´È«÷ŹؽÚÖû»Êõ,minimally invasive total hip arthroplastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©ÎïµÄ°²È«ÐÔ,Security of MedicalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÇÖÊÊèËÉÐÔÐØÑü×µ¹ÇÕÛ,osteoporotic thoracolumbar fractureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Â2΢Çòµ°°×/Äò,beta 2-Microglobulin/urineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ŵºÍÁé50R,Novolin 50RÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ëæ»ú˫äƽÐжÔÕÕ,Randomized double-blind parallel controlÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×㲿»¤Àí,feet careÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡×ÔÎÒ¹ÜÀí,Seflf-management training on diabetesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
÷¾¹Ç¶¤,sacroiliac screwsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
F1µ¥¿Ë¡¿¹Ìå,Monoclonal antibody against Fl Antigen of Y.pestisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÏ໥×÷ÓÃ,cell-cell interactionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢Á¿°×µ°°×/¼¡ôû±ÈÖµ,ratio of microalbumin and creatinineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡ÍªÖ¢ËáÖж¾/Õï¶Ï,diabetic ketoacidosis/DIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ͼ±×µ¹ÇÕÛÍÑλ,subaxial cervical fracture-dislocationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÖÊõºó¸´·¢,Prolapse of Lumbar Intervertebral DiscÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ßäßòÀà/ÖÎÁÆÓ¦ÓÃ,Imidazoles/theraputic useÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȸßÌÇËØÑù¶àëÄ-1,glucagon-like peptide-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÑÉï/ÉÅʳÁÆ·¨,gestational/diet therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡Éñ¾²¡±ä/Õï¶Ï,Diabetic neuropathy/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÜΧÉñ¾ËɽâÊõ,diabetic peripheral neuropathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂåÆÖ,Luopu CountyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐŦÄܼì²â,Measuremem of hean functionsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÊÅÖÖ¢´óÊó,fat ratsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Äò°×µ°°×/¼¡ôû±ÈÖµ,urinary albumin to creatinine ratioÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÆ¤Öʼ¤ËØÀà/¸±×÷ÓÃ,Glucocorticoids/adverse effectsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙ¼²²¡/²¢·¢Ö¢,Pancreatic Diseases/complÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡ÐÔÏÂ֫ȱѪ,Diabetic lower limb ischemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Çŵ±´ÌؽºÄÒ,Lipantil capsuleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÇËè΢Ѫ¹ÜÃܶÈ,bone marrow microvessel densityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
IMBģʽ,IMB modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Áé֥Ƭ,glossy ganoderma pillsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
1-3-¦Â-D-ÆÏ¾ÛÌÇ,1-3-¦Â-D glucanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
άÉúËØB12/ÀàËÆÎïºÍÑÜÉúÎï,Vitamin B12/analogs &derivativesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹¼××´ÏÙÒ©/ÖÎÁÆÓ¦ÓÃ,Antithyroid agents/ therapeutic useÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆÏÌÑÌǵ÷½ÚÒì³£,accommodation abnormality of glucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¬ÖØÂÊ,Overweight rateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
èÛéÚËáĪɳ±ÈÀû·ÖɢƬ,Gastrophageal reflux diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßÉøÐÔ·Ç֢ͪ»èÃÔ,hyperosmolar nonketotic comaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸üÄêÆÚΧ¾ø¾ÆÚ¸¾Å®,Menopause femaleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÕïÁƲÙ×÷,Operation of diagnosis and treatmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡»¼²¡ÂÊ,Rate of DMÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á¬Ðø¶¯Ì¬ÑªÌǼà²â,Continuous glucose monitoring system(CGMS)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
RNA¢óÒÖÖÆëÄ,RNA¢ó-inhibiting peptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Äò΢Á¿°×µ°°×(MAU),Micro-albumin urineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇòÄÒ³ÉÐÎ,expanding plastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿Õ³¦Æ½»¬¼¡,Jejunal smooth muscleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑªÒºÄæÁ÷,Blood back flowÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦ÊȸõÑùϸ°û,enterochromaffin-like cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÇÖÊÊèËÉ»¼²¡ÂÊ,prevalence rate of osteoporosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô·¢ÐÔ/Íâ¿ÆÑ§,primary surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÙҺƤÖÊ´¼,Salivary cortisolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØ×ÔÉíÃâÒß×ÛºÏÕ÷,Insulin autoimmune syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ½á½Ú/Õï¶Ï,Thyroid nodule/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ëæ·Ã¹ÜÀí,Revisit Management of PatientsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³ÖÐøÐÔ¸ßѪÌÇ,Persistent hyperglycemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾«°±Ëá´Ì¼¤ÊÔÑé,Arginine stimulation testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CblÏà¹Øµ°°×,Cbl associated proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ¼²²¡/Õï¶Ï,thyroid diseases/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ°°×ÖÊÀÒ°±ËáÏõ»¯,protein tyrosine nitrationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PKP,Percutaneous kyphoplasieÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
THµ°°×,calcium oxalateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ÷Ö¬ºÏ¼Á,Tiaozhi MisturaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²ÎÜνµÌǽºÄÒ,Shen qi jiang tang capsuleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Äòµ°°×µçÓ¾,proteinuria electrophroresisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÞëϸ°û,chorionic villus cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö¸¼âѪÌÇ,Fingertip blood glucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶à·¢¼Òϵ,Multigene familyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑªË¨ËØB2,6ͪ-ǰÁÐÏÙËØ,Thromboxane B2,6 ¨C keto ¨C ProstaglandinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´óÊóÉöÔà,rat kidneyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎÉö×éÖ¯,hepatic and nephridial tissuesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Æ/Á×,Ca/P ratioÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöСÇòËðÉË,glomerular lesionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʱ³½¸øÒ©,circadian time scheduleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙÉãµâÂÊ,Radioactive iodine uptake rateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|